Codelac neo for adults. "Codelac Neo": reviews, instructions for use
“Codelac” in tablets has long been used in the treatment of dry cough in adults, but an analogue in liquid form called “Codelac Neo” is produced especially for children. It has a slightly different composition and a safer effect, so this remedy is more in demand in childhood against painful dry cough.
Release form
In pharmacies you can find several types of Codelac Neo.
- Drops. This clear, yellowish or colorless liquid is sold in a glass dropper bottle containing 20 ml of solution. The medicine has a sweetish taste and smell of vanilla. Each milliliter of the drug contains 22 drops.
- Syrup. This version of the medicine also tastes sweet, smells like vanilla, is colorless and transparent. It is produced in dark glass bottles containing 100 or 200 ml of the drug. The medicine package contains a 5 ml measuring spoon.
It should be noted that Codelac Neo is also available in tablets, but this medicine is not prescribed to children, since it has a high dosage and a dense shell that does not allow the tablet to be divided into parts.
Compound
The main ingredient in all forms of Codelac Neo is butamirate.
It is presented in medicines in the form of citrate in the following dosage:
- 5 mg in 1 milliliter of drops (100 mg in one bottle);
- 1.5 mg in 1 milliliter of syrup (7.5 mg in one scoop).
The composition of the auxiliary components of both types of liquid medicine is identical and includes benzoic acid, glycerol and sodium hydroxide. To make the product sweet, it contains sorbitol and sodium saccharinate, and vanillin is added to the solution for flavor. These medications contain both ethyl alcohol 95% in small quantities and pure water.
Operating principle
The active substance of the syrup and drops can influence the cough center, which is located in the tissues of the brain. Thanks to this, Codelac Neo suppresses the cough reflex, as a result of which the patient gets rid of an obsessive irritable cough, called dry. In addition, thanks to this medicine, the mucous membrane of the bronchi and upper respiratory tract becomes less reactive, which is why the number of coughing attacks is reduced.
Indications
Codelac Neo is a symptomatic remedy, since the drug affects only one symptom that is characteristic of many diseases of the respiratory system - cough. As already emphasized above, the medication helps eliminate dry cough, so it is in demand in patients with influenza, colds, laryngitis, whooping cough, laryngotracheitis and other pathologies in which the patient coughs often, but practically no sputum is produced.
In addition, drops and syrup are used during operations on the bronchi and before bronchoscopy.
They are also prescribed after acute inflammation of the respiratory tract to get rid of residual unproductive cough.
At what age is it prescribed?
Codelac Neo is an antitussive drug approved for children. This drug can be given in drops even to an infant over two months old. Since the syrup contains a different dosage, this form of medication is prescribed no earlier than the little patient turns 3 years old.
Contraindications
Both liquid forms of Codelac Neo should not be used in the treatment of children who have hypersensitivity to any ingredient of these medications. They should also not be given to children with fructose intolerance. Since the composition of the syrup and drops includes ethanol, for liver pathologies they are prescribed only under the supervision of a doctor.
Patients with epilepsy or brain diseases also require caution.
Side effects
During treatment with Codelac Neo, addiction does not develop and respiratory depression is not observed. However, some children may react to such drugs with drowsiness, nausea, allergic reactions, dizziness, loose stools and other ailments.
In such a situation, you need to consult a doctor and, if necessary, replace Codelac Neo with an equally effective analogue.
How to use?
To eliminate night cough, the last dose is recommended at night.
If after 5 days from the start of use the cough still persists, you need to be examined again by a doctor.
The single dosage of drops is affected by the age of the baby:
- A baby up to one year old is given 10 drops per dose;
- for a child 1–3 years old – 15 drops at a time;
- for a patient over 3 years old - 25 drops per application.
The dosage of syrup is also determined depending on age:
- children 3–6 years old are prescribed 5 ml;
- Patients 6–12 years old are given 10 ml of syrup per appointment;
- from 12 years of age, the single dose is increased to 15 ml of syrup.
Overdose
If a child accidentally drinks more Codelac Neo than he is supposed to by age, this can lead to an attack of vomiting, a decrease in heart rate, drowsiness, arrhythmia and other symptoms. If an overdose is detected, it is recommended to consult a doctor.
Drug interactions
The instructions for Codelac Neo drugs indicate that they are not recommended for use together with any drugs that have a depressant effect on the central nervous system (for example, with sleeping pills or antipsychotics).
In addition, due to blocking the cough reflex, Codelac Neo should not be used with expectorants.
Terms of sale and storage
Both types of Codelac Neo are classified as over-the-counter medications, sold without problems in any pharmacy. On average, you need to pay 150 rubles for 100 ml of syrup, and the price of one bottle of drops is 250–280 rubles.
You can store such medications at home at room temperature, placing the bottle in a dry place where small children will not find it. The shelf life of both liquid medicines is 2 years from the date of manufacture.
Reviews
You can see quite a lot of positive reviews about the use of Codelac Neo. Mothers confirm the effectiveness of such medications for dry cough. Among the advantages of the drops are the possibility of use in infants and ease of dosing. Both liquid versions of the medicine have a pleasant odor and sweetish taste, so children usually do not have any problems swallowing them.
Among the disadvantages, side effects are usually mentioned, which rarely occur in young patients.
Analogs
If you need to replace the syrup or drops with a similar medicine, the doctor may prescribe another drug from the Codelac line of antitussives.
- Codelac tablets, containing codeine, licorice, sodium bicarbonate and thermopsis. Its ingredients suppress the cough reflex, reduce the viscosity of secretions, facilitating easier coughing up of mucus, so the drug is especially in demand in the treatment of dry cough. It can be used from 2 years of age.
- "Codelac Phyto"- a liquid analogue of the drug in tablets, in which instead of sodium bicarbonate there is an extract from thyme. This elixir affects the cough center and the condition of sputum. It is prescribed from the age of two for laryngotracheitis, whooping cough, influenza and other diseases.
- "Codelac Broncho". This medicine in tablets is also similar to the usual Codelac, but the codeine in it is replaced with ambroxol, which gives the medication stronger expectorant properties and eliminates the effect on the brain. It is allowed to be used in children from 12 years of age. There is also a liquid form of the drug "Broncho", prescribed from the age of two. It is represented by an elixir, in which ambroxol is supplemented with glycyrrhizic acid and thyme extract. Both medications are used for inflammatory processes in which very viscous sputum is produced, for example, with bronchitis.
Active substance
ATX:
Pharmacological group
Nosological classification (ICD-10)
Compound
| 1 table | |
| active substance: | |
| butamirate citrate (in terms of 100% substance) | 50 mg |
| Excipients: lactose monohydrate (milk sugar) - 241 mg; hypromellose (methocel K4M) - 85 mg; talc - 4 mg; magnesium stearate - 4 mg; colloidal silicon dioxide (Aerosil) - 6 mg; low molecular weight povidone (low molecular weight polyvinylpyrrolidone) – 5 mg | |
| film shell: Opadry II white 57M280000 (in powder form containing hypromellose (15 cP) - 5.58 mg, titanium dioxide - 4.86 mg, polydextrose - 4.68 mg, talc - 1.26 mg, maltodextrin/dextrin - 0.9 mg , glycerin/glycerol - 0.72 mg) - 18 mg |
Description of the dosage form
Drops: liquid from colorless to colorless with a yellowish tint, transparent or slightly opalescent, with the smell of vanilla.
Syrup: colorless liquid with a vanilla odor.
Pills: round, biconvex, covered with a white film shell. On a cross section it is white or almost white.
pharmachologic effect
pharmachologic effect- anti-inflammatory, bronchodilator, expectorant, antitussive.
Pharmacodynamics
A non-opioid antitussive agent that has a direct effect on the cough center. Butamirate citrate is neither chemically nor pharmacologically related to opium alkaloids. It has an antitussive, expectorant, moderate bronchodilator and anti-inflammatory effect, improves spirometry (reduces airway resistance) and blood oxygenation.
Pharmacokinetics
Oral drops, syrup
Suction. After oral administration, the drug is quickly and completely absorbed from the gastrointestinal tract. After taking 150 mg of butamirate, the Cmax of the main metabolite (2-phenylbutyric acid) in the blood plasma is reached after approximately 1.5 hours and is 6.4 μg/ml.
Distribution and metabolism. Hydrolysis of butamirate, initially to 2-phenylbutyric acid and diethylaminoethoxyethanol, begins in the blood. These metabolites also have antitussive activity, and, like butamirate, are largely (about 95%) bound to plasma proteins, which determines their long half-life. 2-phenylbutyric acid is partially metabolized by hydroxylation.
When taking the drug again, cumulation is not observed.
Excretion. T1/2 is 6 hours. All three metabolites are excreted mainly in the urine. Moreover, 2-phenylbutyric acid is mainly excreted in the form associated with glucuronic acid.
Modified-release film-coated tablets
Absorption is high. After oral administration of a modified-release tablet, Cmax in plasma of the main metabolite (2-phenylbutyric acid) is observed after 9 hours and is 1.4 μg/ml.
Hydrolysis of butamirate, initially to 2-phenylbutyric acid and diethylaminoethoxyethanol, begins in the blood. These metabolites also have antitussive activity, and, like butamirate, are largely (about 95%) bound to plasma proteins, which determines their long half-life. 2-phenylbutyric acid is partially metabolized by hydroxylation. When taking the drug again, cumulation is not observed.
T 1/2 butamirate - 13 hours. Metabolites are excreted mainly by the kidneys. Moreover, 2-phenylbutyric acid is mainly excreted in the form associated with glucuronic acid.
Indications for Codelac® Neo
dry cough of any etiology (for colds, flu, whooping cough and other conditions);
suppression of cough in the preoperative and postoperative period, during surgical interventions and bronchoscopy.
Contraindications
hypersensitivity to the components of the drug;
pregnancy (first trimester);
breastfeeding period;
fructose intolerance (oral drops, syrup);
lactose intolerance, lactase deficiency, glucose-galactose malabsorption (modified-release film-coated tablets)
children up to 2 months (oral drops), up to 3 years (syrup), up to 18 years (modified-release film-coated tablets).
Use during pregnancy and breastfeeding
There is no data on the safety of the drug during pregnancy and its passage through the placental barrier. The use of the drug in the first trimester of pregnancy is contraindicated. In the second and third trimesters of pregnancy, the use of the drug is possible taking into account the ratio of benefits to the mother and potential risk to the fetus.
The penetration of the drug into breast milk has not been studied, therefore the use of the drug during breastfeeding is not recommended.
Side effects
From the central nervous system: dizziness that goes away when the drug is stopped or the dose is reduced; drowsiness.
From the digestive system: nausea, vomiting, diarrhea.
From the skin: exanthema.
Allergic reactions: skin rash, itching.
Interaction
No drug interactions have been reported for butamirate. During treatment with the drug, it is not recommended to drink alcoholic beverages, as well as drugs that depress the central nervous system (including sleeping pills, antipsychotics, tranquilizers).
Directions for use and doses
Inside, before eating.
If the cough persists more than 5 days after starting treatment, you should consult a doctor.
Drops for oral administration
Children from 2 to 12 months - 10 drops 4 times a day; from 1 year to 3 years - 15 drops 4 times a day; over 3 years old - 25 drops 4 times a day.
Before using the drug in children under 2 years of age, you should consult your doctor.
Drops for oral administration, 5 mg/ml (1 ml contains 22 drops).
Syrup
Children from 3 to 6 years old - 5 ml 3 times a day; from 6 to 12 years - 10 ml 3 times a day; 12 years and older - 15 ml 3 times a day; adults - 15 ml 4 times a day.
When taking the drug, you should use a measuring device.
Modified-release film-coated tablets
Without chewing. 1 table each every 8-12 hours
Overdose
Symptoms: nausea, vomiting, drowsiness, diarrhea, abdominal pain, dizziness, irritability, decreased blood pressure, impaired coordination of movements.
Treatment: prescribing activated carbon, gastric lavage, saline laxatives, symptomatic therapy (according to indications).
special instructions
There is a danger when using the drug in patients with a tendency to develop drug dependence, with liver diseases, alcoholism, epilepsy, and brain diseases.
Drops for oral administration, syrup. The drug can be used by patients with diabetes mellitus, because No sucrose or glucose is used as a sweetener.
Modified-release film-coated tablets. Each tablet contains 241 mg of lactose. The drug is contraindicated in patients with lactose intolerance, lactase deficiency, and glucose-galactose malabsorption.
In pediatric practice, the drug Codelac is widely used to treat cough in children. It is available in various forms, so every mother can choose the most convenient product for her child. In addition to the fact that this medicine effectively and quickly eliminates the symptoms of respiratory tract diseases, it is safe for the sensitive child’s body. In order to understand what type of drug is suitable for a child, it is recommended to carefully study the information about each form of the drug.
Description and release forms of Codelac series drugs
The drug is produced by the pharmaceutical company PJSC OTCPharm, a leader in sales of drugs sold without a prescription on the Russian market. The Codelac brand includes the following antitussive drugs:
- Codelac Neo drops and syrup;
- elixir and tablets Codelac Broncho with thyme;
- Codelac Pulmo gel.
Codelac Neo
Codelac Neo for young patients is available in the form of drops and syrup. Drops are used to treat children from 2 months, syrup - from 3 years. Such dosage forms are easy to use even for the youngest children. Children like the mild sweet taste and pleasant unobtrusive vanilla smell, and they drink the medicine with great pleasure. Detailed information on the release forms of Codelac Neo is presented in the table.
| Characteristic sign | Release form | |
| Drops | Syrup | |
| Appearance | Transparent liquid without color or with a yellowish tint and vanilla aroma. | Colorless solution with a sweetish taste and vanilla aroma. |
| Packing | Glass dropper bottles with a volume of 20 ml (440 drops) with a plastic screw cap. Packaged in a colorful box made of thick cardboard. | Glass bottles of 100 and 200 ml with a plastic screw cap. The medicine is packaged in a rectangular cardboard box. Each package comes with a double-sided plastic measuring spoon for 2.5 and 5 ml. |
| Compound | Butamirate citrate, sorbitol syrup, glycerin, ethyl alcohol 95%, sweetener E954, preservative E210, vanillin, sodium hydroxide solution 30%. | |
There are also Codelac Neo tablets, but this dosage form is approved for use in patients over 18 years of age.
Codelac Broncho
Codelac Broncho with thyme for babies is available in the form of an elixir and tablets. The first dosage form is used to treat children from 2 years old, the second - from 12 years old. Due to the absence of alcohol, sugar and artificial colors, the elixir is absolutely safe for sensitive children's health. Information on the release forms of Codelac Broncho with thyme is presented in the table.
| Characteristic sign | Release form | |
| Elixir | Pills | |
| Appearance | The liquid is light brown or brown in color. During storage, sediment may form. | Pressed powder of a light cream or yellowish hue, flat cylindrical shape, with dark and light inclusions, rounded edges and a dividing strip. |
| Packing | Glass bottles of 100 ml (for children) and 200 ml (for adults), with a plastic screw cap. Packaged in a thick cardboard box. Each package comes with a double-sided plastic measuring spoon for 2.5 and 5 ml. | Blister pack of 10 tablets. Each box of the drug contains 1 or 2 blisters with 10/20 tablets, respectively. The medicine is packaged in a rectangular thick cardboard box. |
| Compound | Ambroxol hydrochloride, sodium glycyrrhizinate, liquid thyme extract, preservative E218, nipazole, sorbitol syrup. | Ambroxol, sodium glycyrrhizinate, thermopsis dry extract, sodium bicarbonate, potato starch, microcrystalline cellulose, povidone, talc, stearic acid, sodium carboxymethyl starch. |
Codelac Pulmo
Codelac Pulmo is available in the form of a cosmetic massage gel. It includes the following auxiliary components:
- gum turpentine;
- glycerol;
- racemic camphor;
- vegetable and fir oil;
- vinylin;
- aristoflex;
- germaben;
- polyethylene glycol;
- red pepper extract.
The gel is a white cream with a light and non-greasy consistency. The medicine, 50 ml, is packaged in a soft plastic tube with a screw cap. Codelac Pulmo is approved for use in children over 3 years of age.
Indications for use and contraindications
Each of the medicines in the Codelac line, intended for use by young patients, has minor contraindications.
Before giving your child drops or syrup, you must make sure that he has no restrictions on the use of the medicine. If a child has a predisposition to developing drug dependence, liver and brain diseases, epilepsy, drugs that contain ethyl alcohol should be used with great caution. For clarity, information about the indications and contraindications of Codelac is presented in the table.
| Name of the drug | Release form | Indications | Contraindications |
| Codelac Neo | Drops |
|
|
| Syrup |
|
||
| Codelac Broncho with thyme | Elixir |
|
|
| Pills |
|
||
| Codelac Pulmo | Gel | Used as an adjunct to drug therapy to increase blood flow and warm up. |
|
Instructions for use: methods and dosages
If the cough persists for more than 5 days after starting to use the drug, the child should be taken to the pediatrician. The maximum duration of use of syrup and elixir without consulting a doctor is 5 days.| Name of the drug | Release form | Dosage regimen | Method of use | ||
| Age category, years | Single dose | Daily frequency of use, times | |||
| Codelac Neo | Drops | ≤ 1 | 10 drops | 4 | Orally, before meals |
| 1-3 | 15 drops | ||||
| ≥ 3 | 25 drops | ||||
| Syrup | 3-6 | 5 ml | 3 | ||
| 6-12 | 10 ml | ||||
| ≥ 12 | 15 ml | ||||
| Codelac Broncho with thyme | Elixir | 2-6 | 2.5 ml | 3 | Orally during meals with a small amount of water |
| 6-12 | 5 ml | ||||
| ≥ 12 | 10 ml | 4 | |||
| Pills | ≥ 12 | 1 tablet | 3 | Orally during meals with water | |
| Codelac Pulmo | Gel | ≥ 3 | A small amount of | 2-3 | Rub into the skin (chest and back) with massage movements until completely absorbed. |
Side effects and overdose
The drug may cause the following side effects:
- drowsiness;
- dizziness (stops when you stop taking the medicine or reduce the dose);
- nausea and vomiting;
- diarrhea or constipation;
- allergies in the form of hives, itching and skin rashes;
- exanthema;
- dry mouth;
- copious mucus discharge from the nose;
- pain in the stomach area.
An overdose may be accompanied by nausea, vomiting, drowsiness, diarrhea, dizziness, low blood pressure, impaired coordination of movements and indigestion.
If symptoms of overdose appear, you need to induce artificial vomiting or rinse the stomach within 2 hours after taking the medicine, take activated charcoal and a drug with a laxative effect.
Prices and analogues
The cost of the drug depends on the form of release, dosage and region of sale. The price can also be influenced by the form of ownership the pharmacy belongs to - public or private. It is not recommended to buy medicines online, as such a purchase does not guarantee their authenticity and quality. Information on the cost of the drug and names of analogues is presented in the table.
| Name of the drug | Release form | Average price, rub. | Analogs |
| Codelac Neo | Drops | 135-375 | Mukaltin, Cook's Syrup, Bronchalis-Heel, Bronchofit, Bronchoton, Macrotusin, Ambrosol, Herbion, Bronchicum (we recommend reading: instructions for using Mukaltin syrup for children) |
| Syrup 100/200 | 134-168/233-267 | ||
| Codelac Broncho with thyme | Elixir 100/200 | 116-150/220-399 | |
| Tablets 10/20 | 69-315/101-429 | ||
| Codelac Pulmo | Gel 50 ml | 135-298 | Roztiran, Vicks Active balm, balm “Star” |
Codelac Neo- a non-opioid antitussive agent that has a direct effect on the cough center. It has an antitussive, expectorant, moderate bronchodilator and anti-inflammatory effect, improves spirometry (reduces airway resistance) and blood oxygenation. Pharmacokinetics
After oral administration, butamirate is quickly and completely absorbed from the gastrointestinal tract. After taking 150 mg of butamirate, the maximum concentration of the main metabolite (2-phenylbutyric acid) in the blood plasma is reached after approximately 1.5 hours and is 6.4 mcg/ml.
Hydrolysis of butamirate, initially to 2-phenylbutyric acid and diethylaminoethoxyethanol, begins in the blood. These metabolites also have antitussive activity and, like butamirate, are highly (about 95%) bound to plasma proteins, resulting in their long half-life. 2-phenylbutyric acid is partially metabolized by hydroxylation.
When taking the drug again, no accumulation is observed.
The half-life of butamirate is 6 hours. Metabolites are excreted mainly by the kidneys. Moreover, 2-phenylbutyric acid is mainly excreted in the form associated with glucuronic acid.
Indications for use
Syrup Codelac Neo used to treat dry cough of any etiology, including whooping cough; to suppress cough in the preoperative and postoperative period, during surgical interventions and bronchoscopy.Mode of application
Syrup Codelac Neo take orally before meals.Children aged 2 to 12 months - 10 drops 4 times a day; from 1 year to 3 years - 15 drops 4 times a day; over 3 years - 25 drops 4 times a day.
Before using the drug in children under 2 years of age, you should consult your doctor.
Drops for oral administration 5 mg/ml (1 ml contains 22 drops).
If the cough persists more than 5 days after starting treatment, you should consult a doctor.
Side effects
From the central nervous system: dizziness, which goes away when the drug is discontinued or the dose is reduced; drowsiness.From the digestive system: nausea, diarrhea.
Allergic reactions: skin rash, itching.
Other: exanthema.
Contraindications
:Contraindications to the use of the drug Codelac Neo are: hypersensitivity to the components of the drug, fructose intolerance, pregnancy (first trimester), breastfeeding period, children under 2 months of age.
Pregnancy
:There is no data on the safety of the drug Codelac Neo during pregnancy and its passage through the placental barrier. The use of the drug in the first trimester of pregnancy is contraindicated. In the second and third trimesters of pregnancy, the use of the drug is possible taking into account the ratio of benefits to the mother and potential risk to the fetus.
The penetration of the drug into breast milk has not been studied, therefore the use of the drug during breastfeeding is not recommended.
Interaction with other drugs
No drug interactions have been reported for butamirate. During treatment with the drug Codelac Neo It is not recommended to consume alcoholic beverages, as well as medications that depress the central nervous system (hypnotics, antipsychotics, tranquilizers and other drugs).Overdose
Symptoms of syrup overdose Codelac Neo: nausea, vomiting, drowsiness, diarrhea, dizziness, decreased blood pressure, impaired coordination of movements.Treatment: activated carbon, saline laxatives, symptomatic therapy (according to indications).
Storage conditions
At a temperature not higher than 25 oC.Keep out of the reach of children.
Release form
Codelac Neo - syrup for oral administration 1.5 mg/ml.In a dark (amber) glass bottle, 100 and 200 ml. 1 bottle with a measuring spoon in a cardboard pack.
Compound
5 ml Codelac Neo syrup contain the active substance: butamirate citrate (in terms of 100% substance) 7.5 m.Excipients: sorbitol (Neosorb 70/70, sorbitol syrup) - 2025 mg; glycerol (glycerin) - 1450 mg; ethanol 95% (ethyl alcohol 95%) - 12.69 mg; sodium saccharinate - 3 mg; benzoic acid - 5.75 mg; vanillin - 3 mg; sodium hydroxide solution 30% - 1.55 mg; purified water - up to 5 ml
Additionally
A drug Codelac Neo can be used by patients with diabetes, since sucrose or glucose is not used as a sweetener.There is a danger when using the drug in patients with a tendency to develop drug dependence, with liver diseases, alcoholism, epilepsy, and brain diseases.
Impact on the ability to drive a car and operate machinery
It is recommended to refrain from driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions, as the drug can cause dizziness.
Main settings
| Name: | KODELAK NEO |
| ATX code: | R05DB13 - |
Codelac Neo is a centrally acting medicine against dry cough, often prescribed for infections of the ENT organs. Instructions for use of Codelac Neo syrup allow the use of the medication to treat young patients.
Release form and contents of the product
The medicine is produced:
- in bottles with a dropper stopper of 20 ml. Codelac Neo drops are prescribed to infants from 2 months of life;
- in tablet form, 10 pieces per package. The tablets are intended for patients over 18 years of age;
- in the form of syrup in bottles of 100 and 200 ml. Used by children from 3 years of age and adults.
In syrup form, the product is often used to treat young children. The bottle comes with a convenient double-sided spoon for precise dosage of the substance (2.5 and 5 ml).
Most often, syrup is prescribed as part of complex therapy simultaneously with other anti-inflammatory drugs and antibiotics. The liquid form of the product tastes good, has a slight vanilla scent, and is well tolerated by children.
Codelac Neo contains the main ingredient - butamirate citrate. Auxiliary components include sorbitol, glycerol, ethyl alcohol and others.
Therapeutic properties
Codelac Neo cough syrup is an antitussive medicine that acts directly on the receptors of the cough center. Due to the main component butamirate citrate, the medication suppresses attacks of dry cough, reduces inflammation and expectorates phlegm. The highest concentration of substances occurs 90 minutes after consumption. The drug is excreted from the body by the kidneys after 6 hours.
In addition to its expectorant properties, the syrup helps relax the muscles of the bronchi, relieving suffocating attacks.
By directly influencing the cough center, the drug reduces the intensity of spasms, as well as the frequency and strength of coughing, which is especially important in the treatment of whooping cough in young patients. In addition, its antitussive, bronchodilator and anti-inflammatory properties help improve the patient's respiratory abilities.
The main advantages of Codelac Neo are:
- can be used on the recommendation of the attending physician in the 2nd and 3rd trimesters of pregnancy;
- the use of syrup does not suppress respiratory function;
- allowed for use by diabetics: it does not contain sucrose and glucose;
- allowed for use in children over 3 years of age;
- does not contain codeine, which can cause addiction.
Regular use of Codelac Neo helps to completely eliminate cough. Already after the first use, the drug begins its antitussive effect. A decrease in the intensity of dry cough can be felt on the first day of therapy. The duration of the medicinal effect of the liquid form can last up to 6 hours.
Indications for use
In addition, the medicine is prescribed:
- from dry cough caused by whooping cough;
- after surgical intervention on the bronchopulmonary system;
- before and after bronchoscopy.
The high effectiveness and safety of the main component butamirate in eliminating non-productive cough has been confirmed by clinical trials.
By exerting a selective effect on receptors, the syrup successfully inhibits cough reflexes, relieves irritation of the mucous membranes, due to which the smooth muscles of the bronchi relax.
Instructions for use and dosage
Codelac Neo should be taken on an empty stomach, without diluting the product with water. The required dosage and duration of therapy is determined individually by a medical professional.
Most often, the syrup is taken for 3 to 5 days. Codelac Neo syrup for children is prescribed in the following doses:
- from 3 to 6 years – 1 measuring spoon (5 ml) three times a day;
- from 6 to 12 years – 2 measuring spoons;
- adolescents over 12 years old – 3 scoops 3 times a day;
- adults – 15 ml (3 scoops) four times a day.
If there is no positive dynamics from therapy, or if your health worsens, you must stop treatment and consult a specialist.
Contraindications
Restrictions on taking the drug are:
- hypersensitivity to the active or excipients of the drug;
- fructosemia;
- period of bearing a child (1st trimester), breastfeeding stage;
- The baby is less than 3 years old.
The syrup is not suitable for children under 3 years of age: in the treatment of this group of patients, Codelac Neo is used in a different dosage form (drops).
Particular care must be taken in patients with liver and central nervous system diseases, persons suffering from alcoholism and epilepsy, as well as those with a tendency to drug addiction. The syrup should be used with caution in patients with intracranial hypertension.
The medicine can provoke drug dependence, so treatment should not take more than 5 days.
During pregnancy and lactation
Codelac Neo during pregnancy can only be used in the second and third trimester. However, the remedy is not suitable for self-medication: only a medical specialist should weigh the likely threat to the life of the mother and child with the potential benefit.
It is forbidden to take the medicine in the early stages of pregnancy, since there is no data on its penetration through the placenta.
During breastfeeding, the use of the medication is not allowed. If it is necessary to take it, lactation must be suspended: the ability of the drug to penetrate into mother's milk has not yet been studied.
Side effects and overdose
Most often, the medicine is easily tolerated by patients. However, if you are individually intolerant to butamirate, the following negative reactions are likely to occur:
- pain symptoms in the head;
- dizziness;
- loss of strength, weakness;
- bloating;
- pain in the epigastric region;
- appetite disorder;
- skin rash;
- swelling of the nasal passages and upper ENT organs.
Prolonged use of the drug, as well as the use of high doses, can lead to overdose symptoms, manifested in the form of:
- coordination problems;
- dizziness;
- nausea;
- drowsiness;
- stomach upsets;
- reduction of blood pressure indicators;
- gag reflexes.
In this case, the patient requires symptomatic treatment in the form of gastric lavage, as well as taking enterosorbents.
Interaction with other substances
There is currently no data on the interaction of the drug with other drugs. However, during the period of therapy it is necessary to avoid the use of alcohol-containing drinks, as well as medications that affect the functioning of the central nervous system - tranquilizers, sleeping pills, antipsychotic drugs.
In addition, the medication is usually not used together with expectorants that thin the mucus. This combination can provoke the accumulation of mucus in the respiratory organs, which can cause bronchial obstruction and secondary infection.
Terms of sale and storage, price
The medicine is sold in pharmacy chains without a doctor's prescription. The product should be stored at a temperature of no more than 20 degrees. Shelf life – 2 years.
The price of syrup varies between 335 rubles. for 200 ml and 235 rub. for 100 ml. The cost of the drops is 323 rubles, tablets can be purchased at a price of 245 rubles.
Codelac Neo is a potent butamirate-based product that has shown high effectiveness in eliminating dry cough. The medicine is not suitable for self-medication and should be used only on the recommendation of the attending physician.
